By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Asterand today said that its BioSeek subsidiary will screen Amylin Pharmaceuticals' library of compounds to discover peptides with a potential for treating inflammatory conditions.

Under a one-year contract, BioSeek will apply its BioMap predictive human disease models to screen Amylin's library. The new deal builds on earlier similar agreements between the two firms involving peptide screening and related drug discovery activities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.